glp 1 is mounjaro Mounjaro, Zepbound: Generic GLP-1 Drugs May Soon Be Available GLP-1 Explained: The Good, the

Snack: A handful of mixed nuts and a piece of fruit

In fact, many insurance plans in 2026 are: Excluding weight-loss medications altogether Restricting coverage to diabetes treatment only Requiring strict prior authorizations That means even though Wegovy and Zepbound are FDA-approved for weight loss, they are often not covered for that purpose

What should prescribers look for in a compounding pharmacy for GLP-1 medications

Glucagon-like peptide-1 (GLP-1) agonists are an increasingly common treatment for diabetes and obesity in the United States

The decision to initiate pharmacotherapy should involve shared decision-making, considering individual patient values, preferences, treatment goals, and cost considerations, as these medications can be expensive and may face insurance coverage limitations